IRIS Accounts Production v25.3.0.601 15181132 director 2.10.23 31.3.25 31.3.25 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 15181132 2023-10-01 15181132 2025-03-31 15181132 2023-10-02 2025-03-31 15181132 2023-10-01 15181132 ns15:EnglandWales 2023-10-02 2025-03-31 15181132 ns14:PoundSterling 2023-10-02 2025-03-31 15181132 ns10:Director1 2023-10-02 2025-03-31 15181132 ns10:PrivateLimitedCompanyLtd 2023-10-02 2025-03-31 15181132 ns10:SmallEntities 2023-10-02 2025-03-31 15181132 ns10:AuditExempt-NoAccountantsReport 2023-10-02 2025-03-31 15181132 ns10:SmallCompaniesRegimeForDirectorsReport 2023-10-02 2025-03-31 15181132 ns10:SmallCompaniesRegimeForAccounts 2023-10-02 2025-03-31 15181132 ns10:FullAccounts 2023-10-02 2025-03-31 15181132 ns10:RegisteredOffice 2023-10-02 2025-03-31 15181132 ns5:CurrentFinancialInstruments 2025-03-31 15181132 ns5:ShareCapital 2025-03-31 15181132 ns5:RetainedEarningsAccumulatedLosses 2025-03-31

REGISTERED NUMBER: 15181132 (England and Wales)

| UNAUDITED FINANCIAL STATEMENTS

| FOR THE PERIOD

| 2 OCTOBER 2023 TO 31 MARCH 2025

| FOR

| NORTH DALTON DIAGNOSTICS LTD

NORTH DALTON DIAGNOSTICS LTD (REGISTERED NUMBER: 15181132)

CONTENTS OF THE FINANCIAL STATEMENTS

for the Period 2 October 2023 to 31 March 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 3 |

NORTH DALTON DIAGNOSTICS LTD

COMPANY INFORMATION

for the Period 2 October 2023 to 31 March 2025

| DIRECTOR: | O R Byass

| REGISTERED OFFICE: | Foldyard House

| North Dalton

| Driffield

| East Yorkshire

| YO25 9UX

| REGISTERED NUMBER: | 15181132 (England and Wales)

NORTH DALTON DIAGNOSTICS LTD (REGISTERED NUMBER: 15181132)

BALANCE SHEET

31 March 2025

| Notes | £ |

| CURRENT ASSETS

| Cash at bank | 38,365 |  |

| CREDITORS

| Amounts falling due within one year | 4 | 25,072 |  |

| NET CURRENT ASSETS | 13,293 |  |

| TOTAL ASSETS LESS CURRENT LIABILITIES | 13,293 |  |

| CAPITAL AND RESERVES

| Called up share capital | 100 |  |

| Retained earnings | 13,193 |  |

13,293 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 22 October 2025 and were signed by:

O R Byass - Director

NORTH DALTON DIAGNOSTICS LTD (REGISTERED NUMBER: 15181132)

NOTES TO THE FINANCIAL STATEMENTS

for the Period 2 October 2023 to 31 March 2025

1. | STATUTORY INFORMATION

| North Dalton Diagnostics Limited is a private company, limited by shares, registered in England. The registered number of the company is 15181132 and the registered office is at Foldyard House, North Dalton, Driffield, East Yorkshire, United Kingdom, YO25 9UX.

| The financial statements are presented in the Pound Sterling (£) as this is the functional currency of business

| activities.

| The principal activity of the company is other human health activities.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Having regard to liquidity risk, current market conditions and other factors affecting the company, the use of the going concern basis of accounting is appropriate as, in the opinion of the directors, there are no material

| uncertainties related to events or conditions that may cast significant doubt about the ability of the company to continue as a going concern.

| The directors, having taken into the factors discussed above as well as the uncertainties of the current economic environment, have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future.

| Turnover

| Turnover is the amount derived from ordinary activities, measured at the fair value of the consideration received or receivable. Turnover excludes value added tax and trade discounts.

| Turnover from services is recognised on completion of service, or when those services span the year end date, by reference to the stage of completion at the balance sheet date.

| Sales are recognised at the point which the company has fulfilled its contractual obligations and the risks and rewards attached to the product, have been transferred to the customer.

| Taxation

| Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

NORTH DALTON DIAGNOSTICS LTD (REGISTERED NUMBER: 15181132)

NOTES TO THE FINANCIAL STATEMENTS - continued

for the Period 2 October 2023 to 31 March 2025

2. | ACCOUNTING POLICIES - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the period was 1 .

4. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

£ |

| Taxation and social security | 23,291 |  |

| Other creditors | 1,781 |  |

25,072 |  |